SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
24-Mar-21 9:54 PM View: | Turning Point Therapeutics,... (TPTX) | 23-Mar-21 | Option Exercise | 28,435 | $4.67 | $132,906.00 | 691% 4.12K to 32.55K | |
24-Mar-21 9:54 PM View: | Turning Point Therapeutics,... (TPTX) | 23-Mar-21 | Market Option Sale (Planned) | 28,435 | $100.65 | $2,862,080.00 | (87%) 32.55K to 4.12K | |
24-Mar-21 9:54 PM View: | Turning Point Therapeutics,... (TPTX) | 22-Mar-21 | Grant | 1,625 | -- | -- | 65% 2.49K to 4.12K | |
10-Feb-21 5:53 PM View: | Turning Point Therapeutics,... (TPTX) | 08-Feb-21 | Grant | 1,483 | -- | -- | 147% 1.01K to 2.49K | |
08-Jan-21 9:08 PM View: | Turning Point Therapeutics,... (TPTX) | 07-Jan-21 | Option Exercise | 28,438 | $4.67 | $132,918.00 | 747% 3.81K to 32.25K | |
08-Jan-21 9:08 PM View: | Turning Point Therapeutics,... (TPTX) | 07-Jan-21 | Market Option Sale (Planned) | 28,438 | $122.26 | $3,476,770.00 | (88%) 32.25K to 3.81K | (10%) |
08-Jan-21 9:08 PM View: | Turning Point Therapeutics,... (TPTX) | 07-Jan-21 | Market Sale (Planned) | 2,800 | $122.26 | $342,322.00 | (74%) 3.81K to 1.01K | (10%) |
08-Jan-20 4:12 PM View: | Turning Point Therapeutics,... (TPTX) | 10-Dec-19 | Grant | 216 | $31.13 | $6,723.43 | 8% 2.8K to 3.02K | |
24-Apr-19 6:00 PM View: | Turning Point Therapeutics,... (TPTX) | 22-Apr-19 | Purchase | 2,800 | $18.00 | $50,400.00 | 100% 0 to 2.8K |